Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
|
|
Kaleido Biosciences, Inc. (KLDO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/06/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 05/02/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/25/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/25/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/25/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/25/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/18/2022 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities: |
| 04/08/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
| 03/17/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/09/2022 |
8-K
| Quarterly results |
| 03/02/2022 |
4
| van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,087 restricted stock units
@ $1.49, valued at
$3.1k
|
|
| 03/02/2022 |
4
| Korn Jerald (COO & General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,046 restricted stock units
@ $1.49, valued at
$3k
|
|
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/28/2022 |
8-K
| Other Events Interactive Data |
| 01/18/2022 |
4
| van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 350,000 restricted stock units
@ $0 |
|
| 01/18/2022 |
4
| Long Alison S (Chief Medical Officer) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 46,800 restricted stock units
@ $0
Granted 125,000 restricted stock units
@ $0 |
|
| 01/18/2022 |
4
| Korn Jerald (COO & General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 45,240 restricted stock units
@ $0
Granted 250,000 restricted stock units
@ $0 |
|
| 01/18/2022 |
4
| Duke William E. (CFO) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 44,990 restricted stock units
@ $0
Granted 125,000 restricted stock units
@ $0 |
|
| 01/18/2022 |
4
| Menichella Daniel L (CEO) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 70,200 restricted stock units
@ $0
Granted 250,000 restricted stock units
@ $0 |
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/01/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/01/2021 |
8-K
| Quarterly results |
| 10/05/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/03/2021 |
8-K
| Other Events Interactive Data |
| 09/02/2021 |
POS EX
| Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]: |
| 09/02/2021 |
4
| van Hylckama Vlieg Johan (Chief Scientific Officer) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.29, valued at
$251.6k
|
|
| 09/02/2021 |
4
| Korn Jerald (General Counsel) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 100,000 options to buy
@ $6.29, valued at
$629k
|
|
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/11/2021 |
8-K
| Quarterly results |
| 08/09/2021 |
8-K
| Quarterly results |
|
|
|